Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer

Clinical Cancer Research

Volumn 5, Issue 9, 1999, Pages 2297-2303

  Chen, Xu Qi ^a   Bonnefoi, Hervé ^c   Diebold Berger, Sophie ^b   Lyautey, Jacqueline ^a   Lederrey, Christine ^a   Faltin Traub, Ellen ^c   Stroun, Maurice ^a   Anker, Philippe ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TUMOR MARKER;

ALLELE; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER STAGING; CHROMOSOME ABERRATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MICROSATELLITE INSTABILITY; NUCLEOTIDE REPEAT; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION;

EID: 0001141523     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Wingo, P. A., Ries, L. A., Parker, S. L., and Heath, C. W. Long-term cancer patient survival in the United States. Cancer Epidemiol. Biomark. Prev., 7: 271-282, 1998.
2. Ransohoff, D. F., and Harris, R. P. Lessons from the mammography screening controversy: can we improve the debate? Ann. Intern. Med., 127: 1029-2034, 1997.
3. Shapiro, S., Venet, W., Strax, P., Venet, L., and Rooeser, R. Ten to 14 year effects of breast cancer on mortality. J. Natl. Cancer Inst., 69: 349-455, 1982.
4. Larsson, L. G., Nystrom, L., Wall, S., Rutqvist, L., Andersson, I., Bjurstam, N., Fagerberg, G., Frisell, J., and Tabar, L. The Swedish randomised mammography screening trials: analysis of their effect on the breast cancer related excess mortality. J. Med. Screen., 3: 129-132, 1996.
5. Kerlikowske, K., Grad, D., and Rubin, S. M. Efficacy of screening mammography a meta-analysis. J. Am. Med. Assoc., 273: 149-154, 1995.
6. Smart, C. R., Hendrick, R. E., and Rudledge, J. H. Benefit of mammography screening in women aged 40 to 49 years: current evidence from randomized controlled trials. Cancer (Phila.), 75: 1619-1626, 1995.
7. Wright, C. J., and Mueller, C. B. Screening mammography and public health policy: the need for perspective. Lancet, 346: 29-32, 1995.
8. Marteau, T. Psychological cost of screening. Br. Med. J., 299: 527-528, 1989.
9. Kattlove, H., Liberati, A., Keeler, E., and Brook, R. Benefits and costs of screening and treatment for early breast cancer. J. Am. Med. Assoc., 273: 142-148, 1995.
10. Margolese, R. Screening mammography in young women: a different perspective. Lancet, 347: 881-882, 1996.
11. Dilhuydy, M. H., and Barreau, B. The debate over mass mammography: is it beneficial for women? Eur. J. Radiol., 24: 86-93, 1997.
12. Kerangueven, F., Noguchi, T., Coulier, F., Allione, F., Wargniez, V., Simony-Lafontaine, J., Longy, M., Jacquemier, J., Sobol, H., Eisinger, F., and Birnbaum, D. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res., 57: 5469-5474, 1997.
13. Leon, S. A., Shapiro, B., Sklaroff, D. M., and Yaros, M. J. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res., 37: 646-650, 1977.
14. Shapiro, B., Chakrabarty, M., Cohn, E. M., and Leon, S. A. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer (Phila.), 51: 2116-2120, 1983.
15. Fournié, G. J., Courtin, J. P., and Laval, F. Plasma DNA as a marker of cancerous cell death. Investigation in patients suffering from lung cancer and in nude mice bearing human tumour. Cancer Lett., 2: 221-227, 1995.
16. Stroun, M., Anker, P., Lyautey, J., Lederrey, C., and Maurice, P. Isolation and characterization of DNA from the plasma of cancer patients. Eur. J. Cancer Clin. Oncol., 28: 707-712, 1987.
17. Stroun, M., Anker, P., Maurice, P., Lyautey, J., Lederrey, C., and Beljanski, M. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology (Basel), 46: 318-322, 1989.
18. Vasyukhin, V., Anker, P., Maurice, P., Lyautey, J., Lederrey, C., and Stroun, M. Point mutations of the N-ras in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br. J. Haematol., 86: 774-779, 1994.
19. Sorenson, G. D., Pribish, D. M., Valone, F. H., Memoli, V. A., Bzik, D. J., and Yao, S. L. Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol. Biomark. Prev., 3: 67-71, 1994.
20. Anker, P., Lefort, F., Vasioukhin, V., Lyautey, J., Lederrey, C., Chen, X. q., Stroun, M., Mulcahy, H. E., and Farthing, M. J. G. K-ras gene mutations in the plasma of colorectal cancer patients. Gastroenterology, 112: 1114-1120, 1997.
21. Mulcahy, H., Anker, P., Lyautey, J., Chen, X. q., Lederrey, C., Farthing, M. J. G., and Stroun, M. K-ras gene mutations in the plasma of pancreatic patients. Clin. Cancer Res., 4: 271-275, 1998.
22. Kopreski, M. S., Benko, F. A., Kwee, C., Leitzel, K., Eskander, E., Lipton, A., and Gocke, C. D. Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer. Br. J. Cancer, 76: 1293-1299, 1997.
23. de Kok, J. B., van Solinge, W. W., Ruers, T. J., Roelofs, R. W., van Muijen, G. N., Willems, J. L., and Swinkels, D. W. Detection of tumour DNA in serum of colorectal cancer patients. Scand. J. Clin. Lab. Investig., 57: 601-604, 1997.
24. Hibi, K., Robinson, C. R., Booker, S., Wu, L., Hamilton, S. R., Sidransky, D., and Jen, J. Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res., 58: 1405-1407, 1998.
25. Silva, J. M., Gonzalez, R., Dominguez, G., Garcia, J. M., Espana, P., and Bonilla, F. TP53 gene mutations in plasma DNA of cancer patients. Genes Chromosomes Cancer, 24: 160-161, 1999.
26. Chen, X. q., Stroun, M., Magnenat, J. L., Nicod, L. P., Kurt, A. M., Lyautey, J., Lederrey, C., and Anker, P. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med., 2: 1033-1035, 1996.
27. Sanchez-Cespedes, M., Monzo, M., Rosell, R., Pifarré, A., Calvo, R., Lopez-Cabrerizo, M. P., and Astudillo, J. Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients. Ann. Oncol., 9: 113-116, 1998.
28. Nawroz, H., Koch, W., Anker, P., Stroun, M., and Sidransky, D. Microsatellite alterations in plasma DNA of head and neck cancer patients. Nat. Med., 2: 1035-1037, 1996.
29. Goessl, C., Heicapell, R., M̈nker, R., Anker, P., Stroun, M., Krause, H., Müller, M., and Miller, K. Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma. Cancer Res., 58: 4728-4732, 1998.
30. Sanchez-Cespedes, E. M., Rosell, M., Sidransky, D., Baylin, S. B., and Herman, J. G. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res., 59: 67-70, 1999.
31. Wong, I. H., Lo, Y. M., Zhang, J., Liew, C. T., Ng, M. H., Wong, N., Lai, P. B., Lau, W. Y., Hjelm, N. M., and Johnson, P. J. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res., 59: 71-73, 1999.
32. Futreal, P. A., Söderksvist, P., Marks, J. R., Iglehart, J. D., Cochran, C., Barret, J. C., and Wiseman, R. W. Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res., 32: 2624-2627, 1992.
33. Radford, D. M., Fair, K. L., Phillips, N. J., Ritter, J. H., Steinbrueck, T., Holt, M. S., and Donis-Keller, H. Allelotyping and ductal carcinoma in situ of the breast: deletion of locion 8p, 13q, 16q, 17p and 17q. Cancer Res., 55: 3399-3405, 1995.
34. Zenklusen, J., Bièche, I., Lidereau, R., and Conti, C. J. (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. Proc. Natl. Acad. Sci. USA, 91: 12155-12158, 1994.
35. Devilee, P., Hermans, J., Eyfjörd, A. L., Borresen, R., Lidereau, R., Sobol, H., Borg, A., Cleton-Jansen, A. M., Olàh, E., Cohen, B. B., Scherneck, S., Hamann, U., Peterlin, B., Caligo, M., Bignon, Y. J., and Maugard, C. Loss of heterozygosity at 7q31 in breast cancer: results from an international collaborative study group. Genes Chromosomes Cancer, 18: 193-199, 1997.
36. Patel, U., Grundfest-Broniatowski, S., Gupta, M., and Banerjee, S. Microsatellite instabilities at five chromosomes in primary breast tumors. Oncogene, 12: 3695-3700, 1994.
37. Chuaqui, R. F., Sanz-Ortega, J., Vocke, C., Linehan, W. M., Sanz-Esponera, J., Zhuang, Z., Emmert-Buck, M. R., and Merino, M. J. Loss of heterozygosity on the short arm of chromosome 8 in male breast carcinomas. Cancer Res., 55: 4995-4998, 1995.
38. Radford, D. M., Fair, K. L., Phillips, N. J., Ritter, J. H., Steinbrueck, T., Holt, M. S., and Donis-Keller, H. Allelotyping of ductal carcinoma in situ of the breast: deletion of locion 8p, 13q, 17p, and 17q. Cancer Res., 55: 3399-3405, 1995.
39. Radford, D., Philippe, N. J., Fair, K. L., Ritter, J. H., Holt, M., and Donis-Keller, H. Allelic loss and the progression of breast cancer. Cancer Res., 55: 5180-5183, 1995.
40. Dorion-Bonnet, F., Mautalen, S., Hostein, I., and Longy, M. Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers. Genes Chromosomes Cancer, 14: 171-181, 1995.
41. Skirnisdottir, S., Eiriksdottir, G., Baldursson, T., Barkardottir, R. B., Egilsson, V., and Ingvarrson, S. High frequency of allelic imbalance at chromosome region 16q22-23 in human breast cancer: correlation with high PgR and low S phase. Int. J. Cancer, 64: 112-116, 1995.
42. Fujii, H., Szumel, R., Marsh, C., Zhou, W., and Gabrielson, E. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast. Cancer Res., 56: 5260-5265, 1996.
43. Shaw, J. A., Walsh, T., Chappell, S. A., Carey, N., Johnson, K., and Walker, R. A. Microsatellite instability in early sporadic breast cancer. Br. J. Cancer, 73: 1393-1397, 1996.
44. Ahrendt, S. A., Chow, J. T., Xu, L. H., Yang, S. C., Eisenberger, C. F., Esteller, M., Herman, J. G., Wu, L., Decker, P. A., Jen, J., and Sidransky, D. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J. Natl. Cancer Inst., 91: 332-339, 1999.
45. Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidranski, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodriguez-Bigas, M. A., Fodde, R., Ranzani, G. N., and Srivastava, S. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res., 58: 5248-5257, 1998.
46. Deng, G., Lu, Y., Zlotnikov, G., Thor, A. D., and Smith, H. S. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science (Washington DC), 274: 2057-2059, 1996.
47. McCulloch, R. K., Sellner, L. N., Papadimitriou, J. M., and Turbett, G. R. The incidence of microsatellite instability and loss of heterozygosity in fibroadenoma of the breast. Breast Cancer Res. Treat., 49: 165-169, 1998.
48. James, V., Kearsley, J., Irving, T, Amemiya, Y., and Cookson, D. Using hair to screen for breast cancer. Nature (Lond.), 398: 33-34, 1999.